Identification of two transcription activation units in the N-terminal domain of the human androgen receptor.
about
Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survivalIsolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cellsRepression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectorsIsolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid systemNegative modulation of androgen receptor transcriptional activity by DaxxA novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancerStructure and function of steroid receptor AF1 transactivation domains: induction of active conformationsAKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR.The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1FHL2, a novel tissue-specific coactivator of the androgen receptorThe cochaperone Bag-1L enhances androgen receptor action via interaction with the NH2-terminal region of the receptorInteraction of the human androgen receptor transactivation function with the general transcription factor TFIIFA sting in the tail: the N-terminal domain of the androgen receptor as a drug targetPathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophyAndrogen Receptor: A Complex Therapeutic Target for Breast CancerActivation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathwaysLigand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cellsActivated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylationAndrogen Receptor Exon 1 Mutation Causes Androgen Insensitivity by Creating Phosphorylation Site and Inhibiting Melanoma Antigen-A11 Activation of NH2- and Carboxyl-terminal Interaction-dependent TransactivationGain in Transcriptional Activity by Primate-specific Coevolution of Melanoma Antigen-A11 and Its Interaction Site in Androgen ReceptorC/EBPalpha redirects androgen receptor signaling through a unique bimodal interactionTALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer.Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancerAndrogen insensitivity.Analysis of exon 1 mutations in the androgen receptor gene.Severe forms of partial androgen insensitivity syndrome due to p.L830F novel mutation in androgen receptor gene in a Brazilian family.A novel mutation (N233K) in the transactivating domain and the N756S mutation in the ligand binding domain of the androgen receptor gene are associated with male infertility.Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells.The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists.Intrinsic disorder in the androgen receptor: identification, characterisation and drugability.The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cellsIs GSN significant for hip BMD in female Caucasians?Pax6 represses androgen receptor-mediated transactivation by inhibiting recruitment of the coactivator SPBP.Cyclin D1: mechanism and consequence of androgen receptor co-repressor activity.Aging impairs VEGF-mediated, androgen-dependent regulation of angiogenesisART-27, an androgen receptor coactivator regulated in prostate development and cancer.Modeling truncated AR expression in a natural androgen responsive environment and identification of RHOB as a direct transcriptional target.Development of selective androgen receptor modulators (SARMs).Hormone depletion-insensitivity of prostate cancer cells is supported by the AR without binding to classical response elements.Androgen receptor signaling in prostate cancer development and progression.
P2860
Q21091046-2638640D-40B4-47E8-8907-C7B4D3E76C3BQ22010448-3D22469E-9ED3-4AED-B6A2-5D2EB978F404Q24298419-0AFEED52-866B-4548-B46E-4E26187CEA8BQ24308929-158F67BF-308F-47CA-92EC-13D28636E634Q24318233-6FCBC568-E980-4058-A7EB-48D490B5A0CEQ24338270-9D7CD76B-5ABF-41CA-AB39-7C192D30D742Q24537137-EB15A9D1-27B2-4359-A9AF-36C5DDA08936Q24540534-B7292EDC-6E0A-48D2-ABCC-AE7F8DF21D31Q24554379-1C9BAF0A-31AB-4FCA-9B44-ECFC2726FEA6Q24601620-AD6781E7-55B3-44F4-BE59-F660C3ACFF85Q24652993-7B2157C5-CDD1-4FE5-A09F-84AE511467ACQ24654156-58B06B63-B2EA-4F8F-939A-E307937A68CEQ26747094-B0425280-0BEF-4F98-9B21-FE7BF7242D6EQ27007098-17DAA27B-6569-4115-852E-1291E4B60409Q28075188-74F99407-3D5B-4771-B4CE-7B833A7AE0A2Q28212733-332D42B8-3B55-465D-98CE-5013B316DFC1Q28217019-D030C5F6-1AB4-4028-96AB-A3592B6CE7F6Q28301664-88029BF5-6BD4-4729-A461-86BB76F453E7Q29036974-7B0BAFEE-C24A-4DC1-A3D8-A57669924C0FQ29040033-24426F8A-2E6D-4701-833B-E05203793F87Q30446961-723AE1FB-E288-4ECF-894C-FD1E2AEC5FD5Q30554439-737D31A7-EC41-46CD-BC29-DDA73D6F8480Q33823702-E206B80F-FA57-4EA7-B8CD-FC7946A16B8CQ33869547-2114544F-7444-4A71-BEAF-0E67793E524CQ33881302-398179A5-11D5-4EB3-919F-745F1505CB5FQ33924607-544D0799-5DC3-4A5C-9C52-856BEBBB1078Q33952675-CC5E0AF4-A4B9-42BD-9CAA-C09A0FF72974Q33976024-FADEEED1-26C2-474D-BFC7-7F20C0E7E975Q33983786-D30A003E-500E-4DD1-888F-311FA6DBA959Q33984776-EE5A7DE2-9CD8-4434-BA4E-9CD2E13C8E93Q34022799-7F3508D9-F4F3-4FC8-8A96-570C05F31420Q34024780-FEC089B8-F011-42B7-A488-FF9CB214A4D9Q34026199-A4B7C7FE-9D60-41D0-A021-10DD36B7588FQ34102421-A83B78DD-BA4F-4DC4-AA4E-5AEA64266315Q34131666-C3663631-B22E-4565-897D-A62984D87B56Q34288622-7F3EA50B-DC85-462E-955C-C34EAF19BFBDQ34499785-1E46224B-9C39-4AFF-B5E3-A4A6134F8CA0Q34558010-09164A54-2565-41FB-93F6-8D85D2C9E643Q34712118-99544ADD-39E4-4598-A171-80EC0863D3CCQ35183663-DB2F2E8D-6FB3-42B2-BBBE-A0F66DFDB03A
P2860
Identification of two transcription activation units in the N-terminal domain of the human androgen receptor.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Identification of two transcri ...... f the human androgen receptor.
@ast
Identification of two transcri ...... f the human androgen receptor.
@en
Identification of two transcri ...... f the human androgen receptor.
@nl
type
label
Identification of two transcri ...... f the human androgen receptor.
@ast
Identification of two transcri ...... f the human androgen receptor.
@en
Identification of two transcri ...... f the human androgen receptor.
@nl
prefLabel
Identification of two transcri ...... f the human androgen receptor.
@ast
Identification of two transcri ...... f the human androgen receptor.
@en
Identification of two transcri ...... f the human androgen receptor.
@nl
P2093
P2860
P356
P1476
Identification of two transcri ...... f the human androgen receptor.
@en
P2093
Brinkmann AO
van der Korput HA
P2860
P304
P356
10.1074/JBC.270.13.7341
P407
P577
1995-03-01T00:00:00Z